Vicus Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $244K | Buy |
|
|||||
|
2024
Q4 | $221K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $200K | Buy |
|
|||||
|
2024
Q1 | $210K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $280K | Buy |
|
|||||
|
2023
Q2 | $297K | Buy |
|
|||||
|
2023
Q1 | $261K | Buy |
|
|||||
|
2022
Q4 | $270K | Sell |
|
|||||
|
2022
Q3 | $272K | Sell |
|
|||||
|
2022
Q2 | $354K | Sell |
|
|||||
|
2022
Q1 | $506K | Sell |
|
|||||
|
2021
Q4 | $464K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $490K | Buy |
|
|||||
|
2020
Q4 | $473K | Sell |
|
|||||
|
2020
Q3 | $548K | Buy |
|
|||||
|
2020
Q2 | $475K | Buy |
|
|||||
|
2020
Q1 | $449K | Buy |
|
|||||
|
2019
Q4 | $516K | Buy |
|
|||||
|
2019
Q3 | $319K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $321K | Sell |
|
|||||
|
2017
Q2 | $345K | Buy |
|
|||||
|
2017
Q1 | $331K | Buy |
|
|||||
|
2016
Q4 | $348K | Sell |
|
|||||
|
2016
Q3 | $409K | Buy |
|
|||||
|
2016
Q2 | $443K | Buy |
|
|||||
|
2016
Q1 | $358K | Sell |
|
|||||
|
2015
Q4 | $386K | Sell |
|
|||||
|
2015
Q3 | $345K | Buy |
|
|||||
|
2015
Q2 | $384K | Buy |
|
|||||
|
2015
Q1 | $372 | Buy |
|
|||||
|
2014
Q4 | $331K | Sell |
|
|||||
|
2014
Q3 | $298K | Buy |
|